Schedule 13D ownership disclosure
Nuvectis Pharma Inc
Security class unavailable · CUSIP: 67080T108
Event date: 2022-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 21.4600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-038886
- Form type
- SC 13D
- Filer
- BENTSUR RON
- CIK
- CIK 1251213
- Filed
- Mar 28, 2022
- Reporting period
- Mar 17, 2022
- Description
- Schedule 13D beneficial ownership